Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (401-410 of 550) with videos related to

Pageof 55
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
A phase II trial of immunorestoration with zinc gluconate in immunodepressed cancer patientsG Mathé, J L Misset, M Gil-Delgado, et al.
Bulletin Du Cancer|July 1, 1974
[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]J L Amiel, L Schwarzenberg, M Musset, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 7, 1977
[Oncostatic activity of extracts from Alangium vitiense on murine lymphoid neoplasms]M Hayat, G Mathé, E Chenu, et al.
Cancer Research|May 1, 1978
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumorsG Mathé, M Hayat, E Chenu, et al.
Anti-Cancer Drugs|June 1, 1992
Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeB Kim-Triana, J L Misset, J C Madelmont, et al.
La Presse Medicale|October 3, 1970
[The immune response in Hodgkin's disease]M Schneider, L Schwarzenberg, J L Amiel, et al.
Cancer Research|February 1, 1984
Hematological toxicity of repeated injections of (chloro-2-ethyl)-ribofuranosyl-3-nitrosoureaJ L Rebischung, M D Gougeon, K J Mori, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 28, 2001
Hyperthermia-induced cell death by apoptosis in myeloma cellsS Barni, P Pontiggia, V Bertone, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|July 1, 1971
Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in manG Mathé, M Hayat, J L Amiel, et al.
Pageof 55

Showing results (401-410 of 550) with videos related to

Sort By:
Pageof 55
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
A phase II trial of immunorestoration with zinc gluconate in immunodepressed cancer patientsG Mathé, J L Misset, M Gil-Delgado, et al.
Bulletin Du Cancer|July 1, 1974
[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]J L Amiel, L Schwarzenberg, M Musset, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 7, 1977
[Oncostatic activity of extracts from Alangium vitiense on murine lymphoid neoplasms]M Hayat, G Mathé, E Chenu, et al.
Cancer Research|May 1, 1978
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumorsG Mathé, M Hayat, E Chenu, et al.
Anti-Cancer Drugs|June 1, 1992
Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeB Kim-Triana, J L Misset, J C Madelmont, et al.
La Presse Medicale|October 3, 1970
[The immune response in Hodgkin's disease]M Schneider, L Schwarzenberg, J L Amiel, et al.
Cancer Research|February 1, 1984
Hematological toxicity of repeated injections of (chloro-2-ethyl)-ribofuranosyl-3-nitrosoureaJ L Rebischung, M D Gougeon, K J Mori, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 28, 2001
Hyperthermia-induced cell death by apoptosis in myeloma cellsS Barni, P Pontiggia, V Bertone, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|July 1, 1971
Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in manG Mathé, M Hayat, J L Amiel, et al.
Pageof 55